1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; pp. S903 - S904
Main Authors Aroldi, F., Middleton, M.R., Sacco, J.J., Milhem, M.M., Curti, B.D., VanderWalde, A.M., Baum, S.L., Samson, A., Chesney, J., Niu, J., Rhodes, T.D., Bowles, T.L., Olsson-Brown, A., Laux, D.E., Bommareddy, P.K., Menezes, L., Samakoglu, S., Pirzkall, A., Coffin, R.S., Harrington, K.J.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2021
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.1478